• What's involved: An Open-Label Extension and Safety Monitoring Study of Patients with Moderately to Severely Active Crohn's Disease Previously Enrolled in the Etrolizumab.
  • Take part: In set up
  • Principal Investigator: Dr Sunil Samuel
Research Theme | Gastrointestinal & Liver

What's involved

An Open-Label Extension and Safety Monitoring Study of Patients with Moderately to Severely Active Crohn's Disease Previously Enrolled in the Etrolizumab.

Principal Investigator

Dr Sunil Samuel

Take part

In set up
Back to all trials

Website by Volute